Knowledge, attitudes and beliefs about disease and medicine of adolescents living with HIV/AIDS at Surin Hospital by สิทธิโชติวงศ์, รัชนก et al.
ไทยเภสชัศาสตรแ์ละวทิยาการสขุภาพ ปี 9 ฉบับ 2, เมย. – มยิ. 2557 47  Thai Pharm Health Sci J Vol. 9 No. 2, Apr. – Jun. 2014 
 
Knowledge, Attitudes and Beliefs about Disease and Medications 
in Adolescents Living with HIV/AIDS at Surin Hospital  
 
 
นพินธต์น้ฉบบั   Original Article
 
   
รัชนก สทิธโิชตวิงศ์1*, พักตริว์ภิา สวุรรณพรหม2,  
หทัยกาญจน ์เชาวนพูนผล2 และ รัตนาภรณ์ อาวพัินธ์2 
 Ratchanok Sittichotiwong1*, Puckwipa Suwanaprom2,  
Hathaikan Chowwanapoonpohn2 and Ratanaporn Awiphan2 
 
1 กลุม่งานเภสชักรรม โรงพยาบาลสรุนิทร ์อ.เมอืง จ.สรุนิทร ์32000 
2 ภาควชิาบรบิาลเภสชักรรม คณะเภสชัศาสตร ์มหาวทิยาลัยเชยีงใหม ่อ.เมอืง จ.เชยีงใหม ่50200  
 
 1 Department of Pharmacy, Surin Hospital, Surin, Thailand 32000  
2 Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University,  
Chiang Mai, Thailand 50200  
   
* ตดิตอ่ผูน้พินธ:์ ratchas12@yahoo.com   * Corresponding author: ratchas12@yahoo.com 
 
วารสารไทยเภสชัศาสตรแ์ละวทิยาการสขุภาพ 2557;9(2):47-54  Thai Pharmaceutical and Health Science Journal 2014;9(2):47-54 
 
 
 
บทคดัยอ่  
วตัถปุระสงค์: เพื่อสาํรวจความรู ้ทศันคต ิและความเชื่อเกีย่วกบัโรคและยาใน
มุมมองของวยัรุ่นตดิเชื้อเอชไอว/ีเอดสท์ี่ได้รบัการรกัษาด้วยยาต้านไวรสั วิธี
การศึกษา: งานวจิยัเชงิคุณภาพน้ีใชว้ธิกีารสนทนากลุ่มและสมัภาษณ์เชงิลกึใน
กลุ่มวยัรุ่นติดเชื้อเอชไอว/ีเอดส์ที่มารบับรกิาร ณ คลินิกภูมคิุม้กนั โรงพยาบาล
สุรนิทร์ ระหว่างเดือนมนีาคม – พฤษภาคม 2556 โดยใช้คําถามทีส่รา้งขึ้นจาก
แบบจําลองการอธิบายโรค แบบจําลองความเชื่อด้านสุขภาพ และทฤษฎี
พฤตกิรรมตามแผน วเิคราะหข์อ้มลูเชงิเน้ือหา ผลการศึกษา: วยัรุ่นตดิเชือ้เอชไอ
ว/ีเอดสจ์ํานวน 20 คน เขา้ร่วมการสมัภาษณ์เชงิลกึและดําเนินการสนทนากลุ่ม 3 
ครัง้ สําหรับความรู้เกี่ยวกับโรคและยาที่สมัพันธ์กับเอชไอวี/เอดส์พบว่ากลุ่ม
ตวัอยา่งมกีารรบัรูต้ามแบบจาํลองการอธบิายโรคและความเชื่อดา้นสขุภาพว่าเอช
ไอว/ีเอดสเ์ป็นโรคทีร่กัษาไมห่ายขาดและรกัษาไดด้ว้ยการใชย้าตา้นไวรสัเท่านัน้ มี
การรบัรูว้า่ยาตา้นไวรสัจะช่วยใหร้่างกายแขง็แรงขึน้ หากจาํแนกผลการศกึษาตาม
ช่วงกลุ่มอายคุอื วยัรุน่ตอนตน้อาย ุ10 - 15 ปี และวยัรุ่นตอนกลางอาย ุ16 - 18 ปี 
พบว่าทัง้สองกลุ่มมีความรู้ที่แตกต่างกันอย่างชัดเจนคือ กลุ่มวยัรุ่นตอนกลาง
สามารถอธบิายรายละเอยีดไดม้ากกว่าวยัรุ่นตอนตน้ทีย่งัสบัสนและตอบได้เพยีง
คําถามพื้นฐาน ด้านการรบัรู้อุปสรรคของการกินยาพบว่าขนาดของเมด็ยาและ
ผลขา้งเคยีงจากยาเป็นสิง่ทีม่ผีลต่อความรูส้กึของวยัรุ่นมากทีส่ดุเมื่อเกดิการดือ้ยา
ของเชื้อเอชไอว ีส่วนอุปสรรคในการรบัประทานยาต้านไวรสัให้สมํ่าเสมอได้แก่ 
ปญัหาการเดินทางไปโรงพยาบาล คุณสมบัติทางกายภาพของยา กิจวัตร
ประจําวนั และความไม่พร้อมของอุปกรณ์ช่วย นอกจากน้ียงัพบว่าครอบครวัมี
อทิธพิลต่อพฤตกิรรมความร่วมมอืในการรกัษาของวยัรุ่นมากทีสุ่ด สรปุ: วยัรุ่น
ตอนกลางมคีวามรูเ้รือ่งโรคและยาเอชไอว/ีเอดสช์ดัเจนและลกึซึง้กวา่วยัรุ่นตอนตน้ 
มกีารรบัรูต้ามแบบจําลองความเชื่อด้านสุขภาพระดบัมากในทุกด้าน และพบว่า
สมาชกิในครอบครวัเป็นผูม้บีทบาทสาํคญัต่อพฤตกิรรมความร่วมมอืในการรกัษา
ดว้ยยาตา้นไวรสั  
คาํสาํคญั: ความรู,้ ทศันคต,ิ ความเชื่อ, วยัรุน่, เอชไอว/ีเอดส ์ 
 
 
Abstract 
Objective: Objective: To explore knowledge, attitudes and beliefs about 
disease and medication in the perspective of adolescents living with 
HIV/AIDS (ALWHs) and receiving antiretroviral (ARV) therapy. Methods: A 
qualitative research using focus group discussion and in-depth interview to 
explore the knowledge, attitudes and beliefs of ALWHs followed up at 
immunology clinic of Surin hospital, Thailand from March to May 2013 with 
the questions guided by constructs of the Explanatory Model (EM), the 
Health Belief Model (HBM) and the Theory of Planned Behavior (TPB). 
Data were analyzed by content analysis. Results: Twenty ALWHs 
participated in 3-rounded focus group discussions and an individual 
interview. According to the HBM, the findings showed that the ALWHs 
perceived that HIV/AIDS was an incurable disease, and ART was the only 
treatment which also helped them get stronger. Based on the information 
obtained, ALWHs were classified into two groups according to their age; 
early (aged 10 to 15 years) and middle adolescents (aged 16 to 18 years). 
The obvious difference was the middle adolescents were able to explain 
their answers in detail while most of the early adolescents had unclear and 
basic answers. Regarding to the perceived barriers, pill size and side-
effects of ARV drugs were the first concern when they had the ARV drug 
resistance. Barriers to taking ARV drugs regularly were transportation to 
the hospital, physical properties of ARV drugs, their daily activities, and 
unavailability of adherence aids. Their family was the strongest influence on 
their normative belief. Conclusion: Middle ALWHs had clearer and deeper 
explanations about HIV/AID disease and medications than early 
counterparts. Their perceptions according to HBM were in high level. Their 
family members played major roles on their adherence to ARV therapy.  
Keywords: knowledge, attitudes, beliefs, adolescents, HIV/AIDS  
 
Introduction
Acquired Immune Deficiency Syndrome (AIDS) is an 
important public health issue worldwide. Adherence with 
antiretroviral (ARV) therapy (ART) is an important factor to 
achieve the goal of ART. Literature suggests that long-term 
ART with at least 95% adherence is needed to achieve good 
clinical outcomes, and reduce HIV/AIDS related mortality and 
morbidity.1-3 Adherence on ARV drugs has been a challenge 
in all groups of HIV patients. Adolescents living with 
HIV/AIDS were reported as being problematic in maintaining 
optimal treatment adherence.4  
Only 50% of adolescents living with HIV/AIDS (ALWHs) 
were reported to have maintained an undetectable viral load 
at one year after achieving optimal control in a U.S. cohort.5 
In Thailand, patients aged 10 - 19 years had significantly 
less adherence than the younger cohort after receiving 
medications for 288 weeks.6 A lower adherence might be 
ไทยเภสชัศาสตรแ์ละวทิยาการสขุภาพ ปี 9 ฉบับ 2, เมย. – มยิ. 2557 48  Thai Pharm Health Sci J Vol. 9 No. 2, Apr. – Jun. 2014 
related to a finding that Thai HIV-infected teenagers had 
psychosocial difficulties, i.e. depression, suicide ideation, 
stigma, and discrimination, and tried to conceal their HIV 
infection from others.7 Thus, to improve long-term adherence 
with ART, the healthcare team has to pay attention to both 
the patients’ medical and psychosocial factors.8 Studies 
related to psycho-social factors associated with adolescents 
living with HIV/AIDS in Thailand remains very limited. This 
study aimed to explore knowledge, attitudes and beliefs 
about disease and medications in the perspective of ALWHs 
receiving ART.   
  
Methods 
Study Design and Sample 
With its qualitative design, focus group discussion (FGD) 
and in-depth interview (IDI) were used to gain a better 
understanding about knowledge, attitudes and beliefs about 
disease and medications in the perspective of ALWHs. In 
developing questions for the FGDs, we were guided by 
constructs of the Explanatory Model (EM), the Health Belief 
Model (HBM) and the Theory of Planned Behavior (TPB). 
The validity of the questions was assessed by content 
analysis by opinion of three experts including two university 
faculty members with experience in health behavior research 
and a pediatrician caring ALWHs at the immunology clinic, 
Surin hospital. The questions are shown in Table 1.  
Purposive sampling was conducted for this study. The 
study sample was patients followed up at Surin Hospital, a 
regional hospital in the North-East of Thailand, during March 
to May 2013. Eligible participants included those ALWHs 
who (1) were prenatally infected with HIV-1, (2) had been 
taking antiretroviral therapy for at least one year, (3) were at 
the age between 10 - 18 years, (4) had already disclosed 
about their infection status, and (5) were willing to participate 
in the study with their informed consent or informed consent 
from their guardian such as, parent, grandparents, or other 
relatives. This study received ethics approval from the 
Ethical Review Committee of the Faculty of Pharmacy, 
Chiang Mai University (No. 11/2556, issued on Mar. 20, 
2013) and the Ethical Committee of Surin hospital (No. 
33/2555, issued on Aug. 1, 2012).   
 
Table 1 Questions for assessing knowledge, attitudes and 
beliefs about HIV/ AIDS disease and medication for 
focus group discussion.  
Topic 
 
Knowledge of disease and medications  
Cause of HIV/AIDS  
How is HIV-infection transmitted from one person to another? 
What do you think about HIV progression? 
Severity of HIV/AIDS  
What do you think about the difference between HIV-infection and AIDS? 
What make you feared of this disease?  
Treatment of HIV/AIDS  
Why can antiretroviral drugs help you? 
What kind of HIV/AIDS treatment do you think you should receive? 
What are the most important results you hope to receive from HIV/AIDS 
treatment? 
 
Attitudes and beliefs about disease and medications  
Perceived severity of the disease  
Can you die from HIV/AIDS? 
Can HIV/AIDs be cured by anti-retroviral treatment? 
Perceived risk of HIV drug resistance 
Can drug resistance make your disease more complicated? 
What will happen, if you take antiretroviral drugs too late or forget to take the 
drugs? 
Perceived barriers to antiretroviral treatment 
Do you have any transportation problems for coming to the hospital? 
Have you ever had antiretroviral drugs side effects which are intolerable? 
What are the barriers in taking antiretroviral drugs regularly?  
Perceived benefits of treatment with antiretroviral drugs 
 Do antiretroviral drugs have a positive effect on your health? 
Environment that affects adherence with antiretroviral drug therapy 
What are your family’s opinions about your disease?  
What are your friends’ and teachers’ opinions about your disease?  
What are your cousins’ opinions about your disease?  
What do you want from the doctor or healthcare team to improve your 
adherence? 
What can make you feel motivated to take your medication? 
What can make you feel bad for taking your medication? 
What is the level of your intention to take your medication at the right time? 
 
Procedure 
People living with HIV/AIDS who work as volunteers at 
the clinic described the study detail for ALWHs and 
guardians who met the study’s inclusion criteria while they 
were waiting to see the doctor. Those who agreed to 
participate were asked to sign the assent and consent form. 
In this study, there were 3 rounds of FGD and one individual 
interview Each FGD was conducted with 6 - 8 participants in 
a separate room. The moderator was a volunteer at the 
clinic who had close contact with these ALWHs. The 
researcher (RS) served as an observer. An individual 
interview was conducted with an individual who were shy, 
soft-spoken or uncomfortable in sharing information with 
others. It was taken after the FGD in a separate room. The 
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findings and working hypotheses gained from the first group 
was shared with the moderator in order to develop questions 
for the next group sessions. Each FGD took 30 – 40 minutes 
of conversation. The second and third FGDs were taken at 2 
and 4 weeks respectively after the first FGD. After the third 
FGD, with no new relevant data obtained, data saturation 
was reached. All FDGs and interviews were audio-taped and 
verbatim-transcribed.   
 
Data Analysis 
Qualitative content analysis was used for data analysis. 
The content of the interviews and discussions was analyzed 
by three coders which were two of the researchers (RS and 
PS) and the moderator. They familiarized the data by 
independently reading the transcripts then creating a list of 
nodes and coded individually. The coding was then 
compared for consistency. Any unclear points were resolved 
by a discussion between the two researchers. Finally, we 
identified themes, defined concepts and interpreted the data.   
   
Results 
 
A total of twenty participants joined three FGDs. Six 
participants spent 25 minutes in the first FGD. The second 
group with eight participants took 40 minutes of 
conversation; while the last group with six participants took 
30 minutes. One individual interview was conducted after the 
first FGD. Characteristics of the study participants are shown 
in table 2.  
Findings from the interview and discussion showed that 
the early adolescents (aged 10 to 15 years) and middle 
adolescents (aged 16 to 18 years) had different level of 
knowledge about their disease and medications. The 
distribution number of participants each group was shown in 
table 3. The first FGD comprised of 4 early adolescents and 
2 middle adolescents. The second FDG comprised of 2 early 
adolescents and 6 middle adolescents, while there were 3 
children in each age group in the third FGD. Using content 
analysis, the researchers distinguished their core 
understanding regarding the HIV/AIDS by their age group. 
The data saturation grids for early and middle ALWHs are 
shown in tables 4 and 5, respectively.   
 
 
 
Table 2 Characteristics of study participants (N = 20) 
Characteristic Number (%) 
Gender  
 Male 8 (40.0) 
 Female 12 (60.0) 
Age (years)  
 10 – 15 9 (45.0) 
 16 - 18 11 (55.0) 
Education  
 Primary school 7 (35.0) 
 Secondary school 13 (65.0) 
Family income (baht per month)  
 Less than 1,000 10 (50.0) 
 1,000 - 3,000 6 (30.0) 
 More than 3,000 4 (20.0) 
Parents status  
 Living with parents 4 (20.0) 
 Separate from parents 12 (60.0) 
 Parents died 4 (20.0) 
Duration on antiretroviral therapy (years)  
 4 – 7 6 (30.0) 
 8 – 11 5 (25.0) 
 12 – 15 9 (45.0) 
Person who help preparing medications  
 Self  10 (50.0) 
 Caregiver 10 (50.0) 
Number of medications taken each time  
 1 7 (35.0) 
 2 – 3 7 (35.0) 
 More than 3 6 (30.0) 
CD4 levels (cell/ml.)  
 Less than 200 4 (20.0) 
 200 – 350 4 (20.0) 
 More than 350 12 (60.0) 
HIV drug-resistance  
 Yes 4 (20.0) 
 No 16 (80.0) 
Opportunistic infection status  
 Never  5 (25.0) 
 Ever  13 (65.0) 
 Current  2 (10.0) 
 
 
Table 3 Distribution number of participants each group  
FGD Number of 
early ALWHs 
Number of  
middle ALWHs 
Total 
Number 
Time 
(minute) 
First 4 2 6 25 
Second 2 6 8 40 
Third 3 3 6 30 
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Table 4 Data saturation grid for early adolescents living with 
HIV/AIDs at each focus group discussion (FGD)   
Topics 
First FGD  
(n = 4) 
Second FGD  
(n = 2) 
Third FGD  
(n = 3) 
Cause of HIV/AIDS  Don’t know (3) 
Mother to child (1) 
Don’t know (2) Don’t know (2) 
Mother to child (1) 
Severity of HIV/AIDS  Make body weak (4) Make body weak (2) Make body weak (3) 
Treatment of HIV/AIDS  Only by antiretroviral drugs 
(4)  
Hope to be cured (3) 
Only by antiretroviral drugs (2) Only by antiretroviral drugs (3) 
Hope to be cured (1) 
Perceived severity of the 
disease  
Dead (4) 
Will die quickly if not 
received the treatment (1) 
Dead (2) Dead (3) 
Perceived risk of HIV drug 
resistance 
Don’t know cause (3) 
Frequently forgotten was a 
major cause of HIV drug 
resistance (1) 
Don’t know cause (2) Don’t know cause (3) 
Perceived barriers to 
antiretroviral treatment 
Travel expense (1) 
Playing outside at the time 
to take drugs (2) 
Difficulties to travel (1) 
Drugs’ side effect (1) 
Drugs’ side effect (1) 
Playing outside at the time to 
take drugs (1) 
Perceived benefits of 
antiretroviral drugs 
Make body stronger (4) Make body stronger (2) Make body stronger (3) 
Environment that affects 
adherence with 
antiretroviral drug therapy 
Grandmother support (1) 
Aunt support (1) 
Mother support (2) Grandmother support (1) 
 
    
Table 5 Data saturation grid for middle adolescents living with 
HIV/AIDs at each focus group discussion (FGD)   
Topics 
First FGD  
(n = 2) 
Second FGD  
(n = 6) 
Third FGD  
(n = 3) 
Cause of HIV/AIDS  
 
Sexual intercourse (2) 
Mother to child (2) 
Sexual intercourse (6) 
Mother to child (6) 
Contaminated blood (1) 
Sexual intercourse (3) 
Mother to child (3) 
Contaminated blood (1) 
Severity of HIV/AIDS  Makes body weak (2) 
Cause blister (1) 
Cause fungus (1) 
Makes body weak (6) 
Destroyed immune (2) 
HIV is the first stage and 
AIDS is the last stage (4) 
Makes body weak (3) 
Cause blister (1) 
Cause abscess (1) 
HIV is the first stage and AIDS 
is the last stage (2) 
Treatment of HIV/AIDS  
 
Only by antiretroviral drugs 
(2) 
 
Only by antiretroviral drugs 
(2) 
Act by press or kill virus (2) 
Hope to live as normal 
people (5) 
Hope to be cured (1) 
Only by antiretroviral drugs (3) 
Hope to live as normal people 
(2) 
 
Perceived severity of the 
disease  
 
Dead (2) 
 
Dead (6) Dead (3) 
Perceived risk of HIV drug 
resistance 
 
Because forget to take 
drugs, frequently (1) 
Because being late for 
taking drugs (1) 
Increase viral load (1) 
Because forget to take 
drugs, frequently (4) 
Because being late for 
taking drugs (3) 
Called HIV drug resistant (3) 
Decrease CD4 (2) 
Increase viral load (3) 
Because forget to take drugs, 
frequently (2) 
 Because being late for taking 
drugs (2) 
Often get sick (2) 
Decrease CD4 (2) 
Increase viral load (1) 
Perceived barriers to 
antiretroviral treatment 
 
Drugs’ side effect (1) 
Playing outside at the time 
taking drugs (1) 
The clock not available (1) 
Drugs’ side effect (2) 
Too many drugs (2) 
Too big drug (1) 
Difficulty in travelling to the 
hospital (1) 
Doing homework at the time 
taking drugs (2) 
The clock not available (1) 
Drugs’ side effect (1) 
Too big drug (1) 
 
Perceived benefits of 
treatment with antiretroviral 
drugs 
Make body stronger (2) 
Improve immune (1) 
Make body stronger (6) 
Improve immune (3) 
Make body stronger (3) 
Improve immune (2) 
Environment that affects 
adherence with 
antiretroviral drug therapy 
Mother support (1) 
Friends support (1) 
Reminding clock (1) 
Family support (6) 
Reminding clock (3) 
Smaller tablet (1) 
Family support (2) 
Grandmother (1) 
Friends support (1) 
 
Causes of HIV/AIDS  
The middle adolescents informed that HIV could spread 
from one person to another through sexual intercourse and 
from mother to child. Only two of them were able to tell that 
it was through sexual intercourse, from mother to child and 
through contaminated blood. When they were asked to 
further explain their answer, they were unable to explain how 
HIV could transmit through unsafe or unprotected sex. On 
the other hand, none of the early adolescents knew about 
the viral transmission.   
 
Severity of HIV/AIDS  
Body weakness caused by HIV/AIDS   
Most of adolescents explained that HIV/AIDS made their 
body weak. The middle adolescents could better elaborate 
their answers than the early adolescents.  
“It makes our body weak.” A 14-year-old boy 
“It’ll destroy the immune system of our body. We will get 
sick more often.” A 17-year-old girl  
Opportunistic infections and AIDS stage 
Some of the middle adolescents gave additional 
explanations related to opportunistic infections, for example; 
blisters, fungus, abscess. However the early adolescents did 
not know about these conditions. They were confused and 
did not know about the difference between the stages of 
AIDS.   
“I think it’s different, but I don’t know how.” A 14-year-old 
boy 
“It causes blisters to the body. It’s the disease that others 
don’t have. It means others are healthier than us. 
Sometimes we can have kinds of fungus in our brain or 
TB …things like that.” A 18-year-old girl 
“I saw an infected adult having an abscess on his neck, 
needed to be punctured. He said the dirty liquid came 
out a lot. It seemed to hurt him.” A 17-year-old boy 
“I think AIDS seems to be the last stage but HIV is the first 
stage with no symptoms.” A 17-year-old girl 
      
Treatment of HIV/AIDS 
For the treatment of AIDS, all of them agreed that there 
was only one method which was using antiretroviral drugs. 
Most of them said “The only way is taking antiretroviral 
drugs.”  
Antiretroviral drugs  
They had absolute consensus that antiretroviral drugs 
make their body stronger. However, the early adolescents 
could not further explain the effects of the drugs while the 
middle adolescents gave the meaning of “anti-virus” as 
“press” or “kill.”  
“The drugs will resist virus, press them and kill them.” A 16-
year-old boy 
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“… but they can’t completely kill them. So, we have to take 
the drugs perpetually.” A 17-year-old girl 
In addition, they had different levels of expectation from 
the treatment. Most of the middle adolescents hoped to be 
able to live as normal people, but the early adolescents 
wanted a curable treatment in the future. 
“I want to be completely cured.” A 12-year-old girl 
“When I grow up, I want to be a pharmacist. I’ll try to 
discover the medications that can cure (the disease). I’ll 
distribute it to all the patients of this disease.” A 13-year-
old girl 
   
Perceived severity of the disease 
Dead 
Most of adolescents believed that they could die from 
HIV/AIDS. They knew that HIV/AIDS could not be completely 
cured.  
“If we get sick from other diseases, we will also die. AIDS 
patients that don’t receive treatment will die quickly.” A 
15-year-old girl 
An interesting point was that although everyone accepted 
this fact, some of them still showed their hopes towards the 
disease. A 16-year-old boy having encountered HIV 
resistance gave a definition of “being cured.” In his opinion, 
“Taking the drugs regularly will help (the patient) to be 
completely cured, meaning the virus will be reduced to the 
comparable level to a normal person.”   
Another girl (18-year-old) with the same experience 
hopefully said “I think I might be cured in the future. I’ll wait. 
There might be some medications that can do that.” 
 
Perceived risk of HIV drug resistance 
All of adolescents perceived the danger of not taking 
antiretroviral drugs on-time that they would become weak. 
Only the middle adolescents could indicate that “HIV drug 
resistance will occur.” 
Not taking antiretroviral drugs regularly 
They believed that “frequently forgotten or often late in 
taking medication” was a major cause of HIV drug 
resistance.  
“weak … our look will be terrible, have blisters, be unwell, 
get sick easily.” A 16-year-old boy 
“CD4 will decrease. There’ll be more viral load and 
opportunistic infections.” A 18-year-old girl 
   
Perceived barriers to antiretroviral drugs treatment  
Barriers to antiretroviral drugs treatment among ALWHs 
were transportation to the hospital, antiretroviral drugs side 
effects, their daily activities during the time of taking 
antiretroviral drugs, and unavailable of medication reminder. 
Transportation 
The ALWHs’ problem in coming to the hospital included 
travel expenses, difficulties to travel and disturbance of their 
quality of life.   
“For travel expenses, the bus fee is 70 baht per person. I 
come with my grandmother.” A 14-year-old boy 
“It’s far… buses are rarely available … only twice a day.” A 
13-year-old girl 
“My house is far from here. Each time I have to come here, 
I’ve to get up at 05.30 a.m. I take a direct bus but it takes 
a long time” A 17-year-old boy 
Anti-retroviral drugs’ side-effects and physical 
properties  
They had many complaints about antiretroviral drugs 
including side effects (nausea/vomiting), too many items and 
the large size of the pill.  
“I want to vomit after taking DDI, but I have to be patient. If 
it’s not too bad, I’ d love it more.” A 14-year-old girl  
“I have to take so many drugs. They are hard to be 
swallowed.” A 15-year-old boy 
“We’ll need to take a big sized pill and we’ll feel like 
vomiting later after taking them.” A 18-year-old girl with 
experience in HIV drug resistance   
Their activities during the time taking antiretroviral 
drugs 
The early adolescents reported that they were playing 
while it was time to take medications. The middle 
adolescents reported that they were doing their homework or 
playing outside with their friends. For some whose parents 
asked them to prepare their medications themselves, it took 
longer time than having it done by their parents. 
“When I’m playing football with my friends, my 
grandmother called me to take home quickly. I want to 
continue playing.” A 14-year-old boy 
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Unavailability of medication reminder  
This problem was only for the middle adolescents taking 
care of the medications themselves. They had some 
medication taking reminders such as watch, clock or mobile 
telephone. But sometimes those reminders were out of 
order.    
“I think it’s too late to take my drug. When I went to see the 
clock, It’s 7.20 p.m. My watch was not working.” A 18-
year-old girl 
 
Perceived benefits of treatment with antiretroviral drugs  
All the ALWHs knew the benefits of antiretroviral drugs. 
They used the words “make us stronger.” However, the 
infected early adolescents were unable to further explain the 
word “be strong” in their own views. The middle adolescents 
could give clearer explanations that it helped improve the 
immune system. .  
Improved immune system  
“I previously stopped taking the drugs about 1 year. I think, 
the reason that I restarted was that when I didn’t take 
them, I had blisters on my body. My skin wasn’t beautiful. 
I got sick and went to hospital quite often. People who 
saw me might doubt I am AIDS patient.” A 17-year-old 
girl with HIV drug resistance experience  
“After taking the drugs, they’ll resist virus. It makes our skin 
more beautiful. It makes us live longer. I feel better. The 
immune system is improved.” A 17-year-old boy  
    
Social environments that affects antiretroviral drug 
adherence   
Family, friends, teachers and cousins are important 
supporting factors for medical and treatment adherence. It 
highlights the important role of family support. 
Family 
All family members of the infected adolescents knew 
about their infection. All of them had no problem in living 
together.    
“Everyone in my family accepts my situation. This includes 
my father, mother, grandfather, grandmother, uncle and 
aunt, everyone” A 14-year-old boy 
Friends and teachers  
Most adolescents informed that not all friends and 
teachers knew about their infection. Those who knew about 
their infection did not show any signs of abomination. They 
observed that the persons not knowing may have some 
doubts of why they often got sick and went to see the doctor 
frequently.  
“Some of my teachers know. They understand me. When I 
joined my school’s camping, they allowed me to leave 
early. They know I have to be punctual for taking my 
pills. The persons who aren’t aware sometime complain 
why I am often sick.” A 16-year-old girl 
“All my friends who know can accept. Everyone can be 
friends.” A 18-year-old girl 
Cousins 
Most of them reported that their cousins knew about their 
infection but did not show their abomination. Some of them 
said that some cousins did not know.  
“Uncle and aunt living close to my house don’t say 
anything. For those who live far away, some may know, 
some may not.” A 16-year-old girl  
Factors motivated ALWHs to take antiretroviral drugs 
Most of the adolescents told that their family members 
such as maternal grandmother and mother encouraged them 
to adhere with their treatment and enhance their desire to 
take antiretroviral drugs. Besides that, the supporting factors 
were adherence aids, persons helping to prepare the pills, 
and the appearance of the pills.  
Intention to adherence with antiretroviral drugs 
therapy 
Although they had many barriers to regularly taking 
antiretroviral drugs, but all of them had “high” level of their 
intention to take antiretroviral drugs. 
“I think, I have high intention to take my drugs” A 17-year-
old girl 
“Of course, I think I’ll take it on time” A 14-year-old boy 
  
Discussions and Conclusion 
 
This study revealed that adolescents living with HIV/AIDS 
and receiving antiretroviral therapy in South-East region of 
Thailand have a good knowledge about HIV/AIDS. This 
finding is consistent with other studies on non-HIV 
adolescents in South Carolina,9 New York10 and Malaysia.11 
This finding highlights the success of Thailand’s national 
policy on HIV/AIDS treatment, the National Access to 
Antiretroviral Program for people living with HIV/AIDS  
(NAPHA) which provides supports and guidelines targeting 
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improvement of all major components of HIV/AIDS care, 
namely, ARV protocol development, healthcare professional 
training, drug supply chain management, laboratory network 
formation, monitoring and evaluation and multi-sector and 
PHA involvement since 2001.12 As a result, people living with 
HIV/AIDS in Thailand had received enough knowledge about 
disease and medication.  
The middle adolescents have clearer understanding on 
the disease and medications than those younger 
adolescents. The findings suggested that the early 
adolescents need further knowledge about routes of 
transmission and the difference between AIDS and HIV-
infected persons. This could be explained by the fact that the 
early adolescents (aged 10 – 15 years) have a limitation on 
their age potential. In addition, some children might have not 
been informed about the condition because they are not 
ready, both physically and mentally. Furthermore, they might 
not recognize their own illness.13 Similar findings were found 
in Nepalese adolescents where non-HIV/AIDS adolescents 
had moderate level of overall HIV/AIDS knowledge, but 
lacked in knowledge in the areas of mode of transmission 
and prevention of HIV/AIDS.14 Also in Pakistan, non-
HIV/AIDS adolescents had partial knowledge about AIDS 
and its related issues.15  
Our study findings highlight the constructs of the HBM 
that the ALWHs had high perceived benefit from ART. For 
example, they all agreed that ART is only one method of 
treatment for HIV/AIDS. However, there were several 
perceived barriers to ART adherence. The physical 
properties such as taste and size of antiretroviral drugs were 
the first concern. The ALWHs’ daily activities were also an 
important barrier. They were busy playing with friends, doing 
homework or going outside when their guardians called for 
medication taking. This finding may be due to their growing 
to maturity in their late childhood and adolescence.16  
Regarding to the Theory of Planned Behavior, data 
indicated that their family members were the most influential 
on their normative belief. Participants expressed a need for 
family support. They stated that their family members helped 
preparing their medications, reminding them to take 
medications, supporting them in treatment adherence and 
understanding their conditions. Otherwise, they sometimes 
walked away or ignored some friends or teachers for 
avoiding negative consequences, which was different from 
most of adults that decided to disclose their HIV status to 
prevent any rejection from community.17  
From our findings, it is interesting to note that although 
they were HIV infected persons, they still wanted to live as 
normal as uninfected people. They did not to be a stranger. 
They expected to have social opportunities to live longer and 
to have the cure for HIV/AIDS in the future.  
The strength of this study lies in the fact that it focuses 
on the perceptions of HIV-infected adolescents which are 
difficult to access because they are not open to others. We 
had adults living with HIV/AIDS working as volunteers in the 
hospital who had close contact with the ALWHs as the focus 
group discussion moderators Therefore we had open group 
participation. The main limitation of the study was that the 
findings might not be able to generalize to the situation in 
other regions of Thailand.   
In conclusion, this qualitative study revealed that the 
middle adolescents living with HIV/AIDS in Surin hospital 
had a good knowledge about HIV/AIDS, while the early 
adolescents lacked of knowledge in route of transmission 
and the difference between AIDS patients and HIV-infected 
person. They perceived high benefits of antiretroviral 
therapy. Their barriers to taking antiretroviral drugs regularly 
were transportation to the hospital, physical characteristics of 
antiretroviral drugs, their daily activities and unavailability of 
adherence aids. Size and taste of antiretroviral drugs were 
the first concern when they had HIV-drug resistance. Their 
family played a major role on their normative belief. These 
findings should be used for designing future interventions to 
help adolescents living with HIV/AIDS achieve better 
adherence and quality of life.  
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